The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these most trying diseases.
My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.
We should be that leading edge and we should have a system that accommodates it.
I think if not, you're at least not going to be in a position where you have credibility to offer other things to do.
We borrow now 30 cents on every dollar we spend.
We've been off the mark for 20 years.
We've given up our energy independence. We've done so many things that tilt the whole analysis.
I have been working on this for most of the five-years I have been here in the Senate.
All we want as an alternative to certain death is a pathway that allows us access to these therapies at the point where ...
That is why we need the formality of PPA.